|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
| |
Fibrogen Inc 's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Fibrogen Inc |
1 Q 2025 |
FGEN |
180.01 |
-10.01 |
- |
50.95 |
| Sanofi |
4 Q 2024 |
SNY |
49,599.72 |
6,292.16 |
12.69 % |
11,309.76 |
| Novartis Ag |
4 Q 2023 |
NVS |
46,660.00 |
14,854.00 |
31.83 % |
12,407.00 |
| Astrazeneca Plc |
4 Q 2023 |
AZN |
45,811.00 |
5,961.00 |
13.01 % |
6,166.00 |
| Takeda Pharmaceutical Company Limited |
1 Q 2024 |
TAK |
29,166.69 |
986.39 |
3.38 % |
5,739.41 |
| Johnson and Johnson |
1 Q 2025 |
JNJ |
89,331.00 |
21,810.00 |
24.41 % |
13,001.00 |
| Merck and Co Inc |
1 Q 2025 |
MRK |
63,922.00 |
17,451.00 |
27.3 % |
3,061.00 |
| Pfizer Inc |
1 Q 2025 |
PFE |
62,463.00 |
7,912.00 |
12.67 % |
702.00 |
| Eli Lilly And Company |
1 Q 2025 |
LLY |
49,003.20 |
11,106.40 |
22.66 % |
633.10 |
| Bristol myers Squibb Company |
1 Q 2025 |
BMY |
47,636.00 |
5,437.00 |
11.41 % |
1,541.00 |
| Amgen Inc |
4 Q 2024 |
AMGN |
33,424.00 |
4,090.00 |
12.24 % |
1,029.00 |
| Gilead Sciences Inc |
1 Q 2025 |
GILD |
28,735.00 |
5,965.00 |
20.76 % |
3,208.00 |
| Teva Pharmaceutical Industries Limited |
1 Q 2025 |
TEVA |
16,617.00 |
-1,320.00 |
-7.94 % |
-1,293.00 |
| Viatris Inc |
1 Q 2025 |
VTRS |
14,330.20 |
-3,790.10 |
-26.45 % |
-259.60 |
| Regeneron Pharmaceuticals Inc |
1 Q 2025 |
REGN |
14,085.70 |
4,499.30 |
31.94 % |
483.20 |
| Vertex Pharmaceuticals Inc |
1 Q 2025 |
VRTX |
11,099.70 |
-988.90 |
-8.91 % |
-4,484.00 |
| Organon and Co |
1 Q 2025 |
OGN |
6,294.00 |
750.00 |
11.92 % |
-28.00 |
| Beigene Ltd |
1 Q 2025 |
ONC |
0.00 |
0.00 |
- |
-276.85 |
| Sarepta Therapeutics Inc |
1 Q 2025 |
SRPT |
2,233.37 |
-248.39 |
-11.12 % |
-186.42 |
| Alnylam Pharmaceuticals Inc |
1 Q 2025 |
ALNY |
2,348.10 |
-269.70 |
-11.49 % |
337.53 |
| Arrowhead Pharmaceuticals Inc |
1 Q 2025 |
ARWR |
278.34 |
-154.68 |
-55.57 % |
54.36 |
| Legend Biotech Corporation |
4 Q 2023 |
LEGN |
285.14 |
-518.25 |
-181.75 % |
455.69 |
| Morphosys Ag |
4 Q 2023 |
MOR |
266.87 |
-212.50 |
-79.63 % |
122.97 |
| Emergent Biosolutions Inc |
1 Q 2025 |
EBS |
965.40 |
-131.60 |
-13.63 % |
73.80 |
| Keros Therapeutics Inc |
1 Q 2025 |
KROS |
239.20 |
4.21 |
1.76 % |
278.34 |
| Arvinas Inc |
1 Q 2025 |
ARVN |
426.90 |
-46.60 |
-10.92 % |
-12.50 |
| Opko Health Inc |
1 Q 2025 |
OPK |
689.41 |
-39.00 |
-5.66 % |
374.04 |
| Ionis Pharmaceuticals Inc |
1 Q 2025 |
IONS |
941.14 |
-318.52 |
-33.84 % |
-87.87 |
| Bridgebio Pharma Inc |
1 Q 2025 |
BBIO |
127.42 |
-676.80 |
-531.17 % |
65.25 |
| Moderna Inc |
1 Q 2025 |
MRNA |
3,177.00 |
-3,357.00 |
-105.67 % |
-445.00 |
| Myovant Sciences Ltd |
4 Q 2023 |
MYOV |
379.11 |
-183.77 |
-48.47 % |
-211.08 |
| Innoviva Inc |
1 Q 2025 |
INVA |
408.35 |
-59.72 |
-14.63 % |
140.73 |
| Mannkind Corporation |
1 Q 2025 |
MNKD |
297.60 |
30.12 |
10.12 % |
-145.22 |
| Dynavax Technologies Corporation |
1 Q 2025 |
DVAX |
294.62 |
-60.07 |
-20.39 % |
-80.30 |
| Esperion Therapeutics Inc |
1 Q 2025 |
ESPR |
259.57 |
-153.22 |
-59.03 % |
-111.98 |
| Curevac N v |
4 Q 2023 |
CVAC |
60.21 |
-291.39 |
-483.96 % |
34.37 |
| Akebia Therapeutics Inc |
1 Q 2025 |
AKBA |
184.91 |
-45.31 |
-24.51 % |
71.44 |
| Puma Biotechnology Inc |
1 Q 2025 |
PBYI |
232.71 |
38.07 |
16.36 % |
-13.72 |
| Xencor Inc |
1 Q 2025 |
XNCR |
127.23 |
-211.06 |
-165.89 % |
8.54 |
| Arcturus Therapeutics Holdings Inc |
1 Q 2025 |
ARCT |
143.68 |
-68.20 |
-47.47 % |
-71.45 |
| Casi Pharmaceuticals inc |
4 Q 2024 |
CASI |
28.54 |
-39.26 |
-137.57 % |
-18.36 |
| Arcus Biosciences Inc |
1 Q 2025 |
RCUS |
141.00 |
-391.00 |
-277.3 % |
7.00 |
| Anaptysbio inc |
1 Q 2025 |
ANAB |
111.87 |
-140.62 |
-125.7 % |
44.94 |
| Medicure Inc |
4 Q 2024 |
MPH |
16.78 |
-0.80 |
-4.74 % |
2.08 |
| Mirati Therapeutics Inc |
3 Q 2023 |
MRTX |
38.19 |
-725.88 |
-1900.65 % |
-40.13 |
| Xoma Royalty Corporation |
1 Q 2025 |
XOMA |
42.91 |
-9.99 |
-23.29 % |
-47.37 |
| Theravance Biopharma inc |
1 Q 2025 |
TBPH |
65.27 |
-58.33 |
-89.38 % |
56.78 |
| Centessa Pharmaceuticals Plc |
1 Q 2025 |
CNTA |
0.00 |
-223.85 |
- |
-13.06 |
| Integrated Biopharma Inc |
1 Q 2025 |
INBP |
53.38 |
1.25 |
2.35 % |
0.94 |
| Journey Medical Corp |
1 Q 2025 |
DERM |
56.24 |
-8.30 |
-14.76 % |
-2.99 |
| Agios Pharmaceuticals Inc |
4 Q 2024 |
AGIO |
36.50 |
673.73 |
1845.92 % |
-11.96 |
| Nektar Therapeutics |
1 Q 2025 |
NKTR |
87.25 |
-133.04 |
-152.49 % |
-9.75 |
| Bicycle Therapeutics Plc |
1 Q 2025 |
BCYC |
25.72 |
-203.22 |
-790.07 % |
335.98 |
| Wave Life Sciences Ltd |
1 Q 2025 |
WVE |
104.94 |
-112.33 |
-107.04 % |
62.21 |
| Cryo cell International Inc |
1 Q 2025 |
CCEL |
32.10 |
0.13 |
0.4 % |
-0.02 |
| Siga Technologies Inc |
1 Q 2025 |
SIGA |
120.33 |
48.53 |
40.33 % |
18.40 |
| Alpine Immune Sciences Inc |
1 Q 2024 |
ALPN |
56.52 |
-36.84 |
-65.17 % |
18.57 |
| Tango Therapeutics Inc |
1 Q 2025 |
TNGX |
40.99 |
-132.26 |
-322.67 % |
-2.73 |
| Abcellera Biologics Inc |
1 Q 2025 |
ABCL |
23.11 |
-167.87 |
-726.26 % |
35.69 |
| Nuvation Bio Inc |
1 Q 2025 |
NUVB |
10.79 |
-606.38 |
-5622.47 % |
13.47 |
| Xilio Therapeutics inc |
1 Q 2025 |
XLO |
9.27 |
-54.30 |
-585.54 % |
54.12 |
| Aravive Inc |
3 Q 2023 |
ARAV |
7.00 |
-39.85 |
-569.65 % |
13.54 |
| Geovax Labs Inc |
1 Q 2025 |
GOVX |
5.59 |
-24.50 |
-438.17 % |
6.67 |
| Avidity Biosciences Inc |
1 Q 2025 |
RNA |
9.65 |
-385.72 |
-3996.24 % |
71.62 |
| Immuron Limited |
2 Q 2023 |
IMRN |
1.48 |
-3.79 |
-255.78 % |
3.25 |
| Precigen Inc |
1 Q 2025 |
PGEN |
-2.19 |
-156.65 |
- |
-11.69 |
| Vbi Vaccines Inc |
1 Q 2024 |
VBIV |
9.41 |
-83.99 |
-892.47 % |
-27.80 |
| Prometheus Biosciences Inc |
1 Q 2023 |
RXDX |
4.00 |
-150.56 |
-3768.76 % |
-148.86 |
| Immunome Inc |
1 Q 2024 |
IMNM |
12.51 |
-158.11 |
-1264.16 % |
234.61 |
| Chinook Therapeutics Inc |
2 Q 2023 |
KDNY |
5.85 |
-245.65 |
-4199.93 % |
-18.78 |
| Xenetic Biosciences Inc |
1 Q 2025 |
XBIO |
2.58 |
-3.67 |
-142.03 % |
-2.66 |
| Infinity Pharmaceuticals Inc |
2 Q 2023 |
INFI |
2.57 |
-40.95 |
-1593.93 % |
-0.33 |
| Therapeuticsmd Inc |
1 Q 2025 |
TXMD |
1.41 |
-3.44 |
-244.46 % |
-66.51 |
| Renovorx Inc |
1 Q 2025 |
RNXT |
0.00 |
-1.34 |
- |
10.19 |
| Silence Therapeutics Plc |
1 Q 2025 |
SLN |
25.06 |
-43.27 |
-172.67 % |
27.45 |
| Inflarx N v |
4 Q 2023 |
IFRX |
0.07 |
-47.79 |
-67630.69 % |
25.97 |
| Dmk Pharmaceuticals Corporation |
3 Q 2023 |
DMK |
3.53 |
-22.23 |
-630.71 % |
4.22 |
| Hcw Biologics Inc |
1 Q 2025 |
HCWB |
1.45 |
-24.75 |
-1712.81 % |
-2.98 |
| Altimmune inc |
1 Q 2025 |
ALT |
0.02 |
-90.24 |
-451200 % |
-29.87 |
| Alaunos Therapeutics Inc |
1 Q 2025 |
TCRT |
0.00 |
-4.07 |
- |
-3.83 |
| An2 Therapeutics Inc |
1 Q 2025 |
ANTX |
1.35 |
-45.35 |
-3356.99 % |
-4.71 |
| Atreca inc |
3 Q 2023 |
BCEL |
0.00 |
-97.76 |
- |
-7.43 |
| Vincerx Pharma Inc |
1 Q 2025 |
VINC |
0.00 |
-22.65 |
- |
-0.67 |
| Exicure Inc |
1 Q 2025 |
XCUR |
6.81 |
-5.86 |
-86.13 % |
8.85 |
| Nanoviricides inc |
1 Q 2025 |
NNVC |
0.00 |
-9.73 |
- |
-0.71 |
| Biophytis Sa |
4 Q 2023 |
BPTS |
0.00 |
-19.07 |
- |
6.55 |
| Actavia Life Sciences Inc |
1 Q 2024 |
RASP |
0.12 |
-0.41 |
-333.15 % |
0.00 |
| Pardes Biosciences Inc |
2 Q 2023 |
PRDS |
0.00 |
-76.14 |
- |
81.06 |
| Atea Pharmaceuticals Inc |
1 Q 2025 |
AVIR |
0.00 |
-169.52 |
- |
-24.43 |
| Altamira Therapeutics Ltd |
4 Q 2023 |
CYTO |
0.31 |
-26.53 |
-8680.31 % |
0.00 |
| Moonlake Immunotherapeutics |
1 Q 2025 |
MLTX |
0.00 |
-147.83 |
- |
-186.87 |
| Ernexa Therapeutics Inc |
1 Q 2025 |
ERNA |
0.58 |
-46.09 |
-7919.93 % |
-7.29 |
| Transcode Therapeutics Inc |
1 Q 2025 |
RNAZ |
0.00 |
-25.54 |
- |
6.66 |
| Moleculin Biotech Inc |
1 Q 2025 |
MBRX |
0.00 |
-23.23 |
- |
-9.11 |
| Allarity Therapeutics Inc |
1 Q 2025 |
ALLR |
23.79 |
-23.94 |
-100.6 % |
27.71 |
| Oncorus Inc |
1 Q 2023 |
ONCR |
0.00 |
-90.54 |
- |
-54.29 |
| Lianbio |
3 Q 2023 |
LIAN |
0.00 |
-0.87 |
- |
4.59 |
| Contrafect Corporation |
3 Q 2023 |
CFRX |
0.00 |
-24.14 |
- |
0.75 |
| Fulcrum Therapeutics Inc |
1 Q 2025 |
FULC |
10.72 |
-0.51 |
-4.76 % |
2.23 |
| Vera Therapeutics Inc |
1 Q 2025 |
VERA |
0.00 |
-175.46 |
- |
-14.02 |
| Eqrx Inc |
3 Q 2023 |
EQRX |
0.00 |
-259.62 |
- |
-682.35 |
| Unity Biotechnology Inc |
1 Q 2025 |
UBX |
0.00 |
-27.50 |
- |
0.57 |
| Abivax Sa |
4 Q 2023 |
ABVX |
0.00 |
-165.47 |
- |
0.00 |
| Applied Molecular Transport Inc |
3 Q 2023 |
AMTI |
0.00 |
-74.79 |
- |
-58.83 |
| Cellectar Biosciences Inc |
1 Q 2025 |
CLRB |
0.00 |
-24.54 |
- |
-26.13 |
| Atossa Therapeutics Inc |
1 Q 2025 |
ATOS |
0.00 |
-26.34 |
- |
-18.84 |
| Xbiotech Inc |
1 Q 2025 |
XBIT |
8.21 |
-39.41 |
-480.06 % |
-45.14 |
| Alx Oncology Holdings Inc |
1 Q 2025 |
ALXO |
0.00 |
-130.02 |
- |
6.57 |
| Capricor Therapeutics inc |
1 Q 2025 |
CAPR |
22.27 |
-55.06 |
-247.25 % |
22.58 |
| Third Harmonic Bio Inc |
1 Q 2025 |
THRD |
0.00 |
53.45 |
- |
8.80 |
| Elicio Therapeutics Inc |
1 Q 2025 |
ELTX |
29.70 |
-51.28 |
-172.65 % |
6.53 |
| Ibio inc |
1 Q 2025 |
IBIO |
2.11 |
-21.91 |
-1038.83 % |
-1.25 |
| Pyxis Oncology Inc |
1 Q 2025 |
PYXS |
0.00 |
-95.23 |
- |
-15.21 |
| Structure Therapeutics Inc |
1 Q 2025 |
GPCR |
0.00 |
-143.32 |
- |
54.29 |
| Vaxxinity Inc |
4 Q 2023 |
VAXX |
0.00 |
-75.22 |
- |
-29.53 |
| Viracta Therapeutics Inc |
3 Q 2024 |
VIRX |
0.00 |
-43.29 |
- |
0.27 |
| Evelo Biosciences Inc |
3 Q 2023 |
EVLO |
0.00 |
-82.35 |
- |
-52.15 |
| Indaptus Therapeutics Inc |
1 Q 2025 |
INDP |
0.00 |
-15.75 |
- |
-5.85 |
| Synlogic Inc |
1 Q 2025 |
SYBX |
0.71 |
8.52 |
1203.67 % |
-8.60 |
| Medicinova Inc |
1 Q 2025 |
MNOV |
0.00 |
-11.16 |
- |
-10.57 |
| Mineralys Therapeutics Inc |
1 Q 2025 |
MLYS |
0.00 |
-188.51 |
- |
74.59 |
| Astria Therapeutics Inc |
1 Q 2025 |
ATXS |
0.00 |
-108.04 |
- |
-117.79 |
| Globestar Therapeutics Corporation |
2 Q 2024 |
GSTC |
0.00 |
-0.89 |
- |
-0.07 |
| Cohbar Inc |
2 Q 2023 |
CWBR |
0.00 |
-12.69 |
- |
3.31 |
| Serina Therapeutics Inc |
1 Q 2025 |
SER |
0.06 |
-16.03 |
-28623.21 % |
-4.49 |
| Cocrystal Pharma Inc |
1 Q 2025 |
COCP |
2.01 |
-15.85 |
-786.94 % |
-14.92 |
| Imunon Inc |
1 Q 2025 |
IMNN |
0.50 |
-17.79 |
-3558.64 % |
0.52 |
| Benitec Biopharma Inc |
1 Q 2025 |
BNTC |
0.06 |
-27.11 |
-45947.46 % |
89.49 |
| Briacell Therapeutics Corp |
2 Q 2024 |
BCTX |
0.00 |
-4.93 |
- |
-20.39 |
| Biovie Inc |
4 Q 2025 |
BIVI |
0.00 |
-24.27 |
- |
4.18 |
| Roivant Sciences Ltd |
1 Q 2024 |
ROIV |
97.56 |
-356.73 |
-365.67 % |
-3,824.79 |
| Prelude Therapeutics Inc |
1 Q 2025 |
PRLD |
0.00 |
-127.83 |
- |
15.56 |
| Palvella Therapeutics Inc |
1 Q 2025 |
PVLA |
0.00 |
0.00 |
- |
66.59 |
| Iterum Therapeutics Plc |
1 Q 2025 |
ITRM |
14.32 |
-22.56 |
-157.56 % |
5.26 |
| APROX. MARKET |
1 Q |
SUBTOTAL |
624,137.35 |
86,945.96 |
13.93 % |
49,429.64 |
|
